About Caprion biosciences inc.
Caprion Biosciences Inc. is a leading provider of integrated analytical platforms in the field of biosciences. The company, which operates under the brand name CellCarta, offers a wide range of services in immunology, histopathology, proteomics and genomics, as well as digital pathology and AI.
With over 20 years of experience in the industry, Caprion Biosciences has established itself as a trusted partner for pharmaceutical and biotech companies around the world. The company's state-of-the-art facilities are equipped with cutting-edge technologies that enable it to deliver high-quality results quickly and efficiently.
One of Caprion Biosciences' core strengths is its expertise in immunology. The company has developed a range of innovative assays that allow researchers to study immune responses at both the cellular and molecular levels. These assays have been used to support drug development programs across a wide range of therapeutic areas, including oncology, infectious diseases and autoimmune disorders.
In addition to its immunology services, Caprion Biosciences also offers comprehensive histopathology capabilities. Its team of experienced pathologists can provide expert analysis of tissue samples using a variety of techniques such as H&E staining, IHC/IF staining and FISH analysis.
Caprion Biosciences' proteomics platform is another key area of expertise. The company uses advanced mass spectrometry techniques to identify proteins from complex biological samples such as blood plasma or cerebrospinal fluid. This technology has been used to support biomarker discovery programs for various diseases including cancer and Alzheimer's disease.
The genomics division at Caprion Biosciences provides comprehensive sequencing services using state-of-the-art equipment such as Illumina HiSeq X Ten sequencers. Its team can perform whole genome sequencing (WGS), whole exome sequencing (WES) or targeted sequencing depending on the needs of each project.
Digital pathology is an emerging field that is rapidly gaining importance in the biosciences industry. Caprion Biosciences has invested heavily in this area and has developed a range of digital pathology solutions that enable researchers to analyze tissue samples remotely. The company's AI capabilities also allow it to perform automated image analysis, which can significantly reduce the time and cost associated with manual analysis.
Overall, Caprion Biosciences Inc. is a leading provider of integrated analytical platforms in the biosciences industry. Its expertise in immunology, histopathology, proteomics and genomics, as well as its investment in digital pathology and AI technologies, make it an ideal partner for pharmaceutical and biotech companies looking to accelerate their drug development programs.